noxopharm talks partnership with hudson institute of medical research
Published 1 year ago • 234 plays • Length 9:30Download video MP4
Download video MP3
Similar videos
-
1:40
just the facts: noxopharm
-
8:27
noxopharm prepares first-in-human trial for sof-skn™
-
8:15
noxopharm reveals encouraging new pancreatic cancer preclinical study data
-
13:43
noxopharm ceo discusses subsidiary pharmorage and its focus on inflammation and autoimmune diseases
-
22:56
noxopharm details science-driven strategy in new investor presentation
-
3:19
noxopharm (asx:nox) talks clinical trials and applications for ‘nox66’
-
6:16
zerion pharma | interview | investing in life science 2024
-
3:55
bio-pharma services are key to our strategy: novo holdings ceo
-
12:50
graham kelly from noxopharm limited (asx:nox) - the ceo masterclass
-
4:14
noxopharm (asx:nox) talks applications for its cancer drug candidate nox66
-
13:57
noxopharm (asx:nox) | broker briefing investor presentation | july 2021
-
6:07
noxopharm ceo encouraged by positive interim data from noxcovid trial
-
10:12
noxopharm (asx:nox) - research and development program
-
17:18
noxopharm (asx: nox) - webinar presentation
-
5:13
noxopharm (asx:nox) oncology drug developer
-
6:49
noxopharm (asx:nox) talks nox66 brain cancer study
-
28:00
surgery connect - introducing the academy [product webinar may 2024]